4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-10-004346
$MDGLCIK 0001157601operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:50 PM ET
Size
7.2 KB
Accession
0001179110-10-004346
Insider Transaction Report
Form 4
Chadwick Jeremy G
Sr. VP, Pgm Mgmt and Clin Ops
Transactions
- Award
Employee Stock Option (Right to Buy)
2010-03-01+73,425→ 73,425 totalExercise: $4.02Exp: 2020-03-01→ Common Stock (73,425 underlying) - Award
Common Stock
2010-03-01+7,908→ 23,761 total
Footnotes (2)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 100% of the shares on March 1, 2011, provided the Reporting Person remains employed by the Issuer on such date.
- [F2]The option vests as to 25% of the shares on March 1, 2011 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:50 PM ET
- Size
- 7.2 KB